Literature DB >> 15200384

Fabrication of PVC based membrane using nickel porphyrazine as ionophore in the screening of thiocyanate ion in aqueous and real samples.

Azad Kumar1, Rajendra Prasad, Vinod K Gupta.   

Abstract

The [Ni[(TAP)(SBn)8]] complex (I), i.e. ([2,3,7,8,12,13,17,18-octakis(benzylthio)-5,10,15,20-tetraazaporphyrin])nickel(II), has been explored as an ionophore for fabrication of the PVC based membrane electrodes used in the screening of thiocyanate anion (SCN-). The membrane having [Ni[(TAP)(SBn)8]] complex (I) as an electroactive material and dioctylphthalate (DOP) as plasticizer in the PVC matrix with the percentage ratio 5 : 158 : 200 (I : DOP : PVC, % w/w) exhibited a linear response in the concentration range 7.0 x 10(-6)-1.0 x 10(-1) M of SCN- with a sub-Nernstian slope 32.5 +/- 0.2 mV/decade of activity and a fast response time of 10 +/- 2 s. The sensor works well in the pH range 3.0 - 9.5 and could be satisfactorily used in presence of 50 % (v/v) methanol, ethanol and acetone, and is selective for SCN- over a large number of anions with slight interference from iodide (I-) and azide (N3-) if present at a level >or = 1.0 x 10(-5) M. Described electrode works well over a period of six months. The sensor can be successfully applied for the screening of SCN- in both aqueous and real samples and also as indicator electrodes in precipitation titrations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15200384     DOI: 10.2174/1386207043328779

Source DB:  PubMed          Journal:  Comb Chem High Throughput Screen        ISSN: 1386-2073            Impact factor:   1.339


  1 in total

1.  Anti-inflammatory and immunomodulatory effects of RDV-8 [C18H22N2O2S (ethyl 1-butyl-6-methyl-2-phenyl-4-thioxo-1,4-dihydropyrimidine-5-carboxylate)] in a rat model of induced pleurisy and in vitro lymphoproliferation.

Authors:  Marcos Schuch Azambuja; Adroaldo Lunardelli; Robson Henrich Amaral; Fernanda Bordignon Nunes; Eduardo Caberlon; Vinicius Lorini da Costa; Márcio Vinícius Fagundes Donadio; Daniela Nunes Vitor; Alberto da Silva Melo Denizar; Silvio Cunha; Jarbas Rodrigues de Oliveira
Journal:  Inflammopharmacology       Date:  2010-10-28       Impact factor: 4.473

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.